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Abstract
Human immunodeficiency virus type-1 (HIV-1) fitness has been associated with virus entry, a process mediated by the
envelope glycoprotein (Env). We previously described Env genetic diversification in a Zambian, subtype C infected, slow-
progressor child (1157i) in parallel with an evolving neutralizing antibody response. Because of the role the Variable-3 loop
(V3) plays in transmission, cell tropism, neutralization sensitivity, and fitness, longitudinally isolated 1157i C2-V4 alleles were
cloned into HIV-1NL4-3-eGFP and -DsRed2 infectious molecular clones. The fluorescent reporters allowed for dual-infection
competitions between all patient-derived C2-V4 chimeras to quantify the effect of V3 diversification and selection on fitness.
‘Winners’ and ‘losers’ were readily discriminated among the C2-V4 alleles. Exceptional sensitivity for detection of subtle
fitness differences was revealed through analysis of two alleles differing in a single synonymous amino acid. However, when
the outcomes of N = 33 competitions were averaged for each chimera, the aggregate analysis showed that despite
increasing diversification and divergence with time, natural selection of C2-V4 sequences in this individual did not appear to
be producing a ‘survival of the fittest’ evolutionary pattern. Rather, we detected a relatively flat fitness landscape consistent
with mutational robustness. Fitness outcomes were then correlated with individual components of the entry process. Env
incorporation into particles correlated best with fitness, suggesting a role for Env avidity, as opposed to receptor/coreceptor
affinity, in defining fitness. Nevertheless, biochemical analyses did not identify any step in HIV-1 entry as a dominant
determinant of fitness. Our results lead us to conclude that multiple aspects of entry contribute to maintaining adequate
HIV-1 fitness, and there is no surrogate analysis for determining fitness. The capacity for subtle polymorphisms in Env to
nevertheless significantly impact viral fitness suggests fitness is best defined by head-to-head competition.
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Introduction
Human immunodeficiency virus type I (HIV-1) is a positive-
sense RNA virus that replicates via error-prone reverse transcrip-
tion and undergoes inter-strand recombination, introducing
approximately 3.461025 mutations/base pair per replication
cycle [1,2]. These diversification mechanisms result in HIV-1
populations behaving as large, dynamic groups of related, yet
genetically distinct, organisms whose evolutionary characteristics
can be modeled as a quasispecies [3]. Quasispecies diversity
provides HIV-1 with evolutionary flexibility to respond to
environmental selective pressures while maintaining capacity to
produce replication-competent progeny.
HIV-1 diversity facilitates evolution of resistance to antiretro-
viral therapy and escape from host immune responses [4–15].
Effective antiretroviral drugs, such as nucleoside and non-
nucleoside reverse transcriptase inhibitors, protease inhibitors,
and integrase inhibitors, have been developed to impede
enzymatic activities required for HIV-1 replication. [16]. Howev-
er, due to HIV-1 quasispecies diversity, drug resistance develops
within many patients, and transmission of drug resistant variants
between patients remains a concern. The CD8+ T-cell recognition
of MHC class I restricted HIV-1 epitopes presented by infected
cells is thought to play a critical role in controlling viral load [17–
21]. While some MHC I alleles have been associated with
decreased viral load and improved patient prognosis, intrapatient
quasispecies diversity also supports escape from cytotoxic T
lymphocyte (CTL) responses in most individuals [22,23]. More
disturbingly, there are indications that the global HIV-1 popula-
tion may be adapting to avoid CTL selective pressure [24–26].
Therefore, large dynamic populations of subtle sequence variants
allow HIV-1 continue to replicate despite potent environmental
selection imposed by treatment and the immune system.
For our study, as well as many described below, fitness is defined
as the replicative capacity of a viral variant in a defined
environment [27]. Using this definition, a ‘survival of the fittest’
landscape, in its simplest form, can be modeled on a two-
dimensional fitness coordinate system as a series of discrete peaks
representing highly fit variants, and valleys representing low fitness
variants. HIV-1 sequence diversity in Gag, Nef, Pro, and RT
allows viral escape from selective pressures. However, escape
mutants often have less replicative capacity; they are less ‘fit’
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in vitro than the parental strain [6,8,25,28], in the absence of the
selecting agent. Reductions in in vivo fitness, can lead to decreased
viral load, which in turn, hinders disease progression and potential
for virus transmission [29–33].
Humoral immunity, typified by neutralizing antibody (NAb)
responses against HIV-1 Env, develops within months of infection
in most patients [34–37]. The host NAb response exerts selective
pressure on Env leading to the presence of hypervariable regions
(V1–V5) that are thought to undergo almost continual variation
and selection. The variable regions alternate with relatively
conserved regions of Env (C1–C5) that are generally considered
to be immunologically ‘silent’ or highly functionally constrained
[38]. Diversification and selection allow Env to escape neutrali-
zation over the course of infection [34,37,39,40]. Based upon the
observations that CTL and antiretroviral escape mutations in Gag,
Nef, Pro, or RT, incur a fitness cost, one might anticipate that a
similar fitness penalty would be evinced by Env escape mutants.
However, despite the fact that a majority of infected individuals
mount a neutralizing response against Env, clearance of HIV-1
has never been demonstrated, implying that escape from NAb
does not come at a profound fitness cost. This suggests that Env
evolves to maintain fitness while exploring diverse sequence space,
a concept termed mutational robustness, or ‘survival of the flattest’
[41,42]. A two dimensional representation of this concept would
be a fitness plateau where many variants in sequence space are
compatible with adequate replicative fitness.
In the absence of CTL, NAb, or pharmacologic selection, HIV-
1 replicative fitness has been correlated with early events in the
replication cycle including receptor binding, fusion, and entry; all
steps mediated by Env [43,44]. In investigations of relationships
between HIV-1 fitness and disease progression, Quin˜ones-Mateu
et al., found that fitness, assayed in vitro, correlated with disease
progression in vivo [45]. More importantly, env recombinant viruses
duplicated the fitness stratification, suggesting that HIV-1 fitness,
in the absence of drug selection, was a function of Env-mediated
processes. Subsequent reports verified these observations with
alternative approaches and patient samples [43,44,46,47]. Troyer
et al. investigated temporal relationships in the V3-loop region of
HIV-1 in subtype B infected adults and reported a modest
correlation between Env diversification and fitness, as well as the
anticipated higher fitness of X4- versus R5-tropic strains in
individuals who underwent a coreceptor switch. However, the
longitudinal effects of Env diversification on viral fitness in infected
children and particularly those with HIV-1 subtype C, where R5-
X4 transition is less common, has not been longitudinally
investigated. Moreover, the molecular or functional determinants
of fitness within Env remain to be fully elucidated.
Large differences in HIV-1 fitness can be identified via viral
growth kinetics, either by comparatively assaying rates of increase
in reverse transcriptase activity or accumulation of retroviral
proteins; however, these approaches cannot elucidate subtle fitness
differences between HIV-1 variants [15]. In the absence of gross
replicative defects, two variants can have virtually identical in vitro
growth kinetics, yet disparate fitness values [45,46,48]. Thus, viral
fitness is optimally defined by experimentally quantifying viruses in
dual-infection competitions [49]. Recently, recombination be-
tween a reporter provirus and Env PCR products has been used to
produce infectious HIV-1 containing a fluorescent reporter gene.
Competitions between one virus with an eGFP reporter and
another containing a DsRed2 reporter allowed for quantification
of HIV-1 fitness values by flow cytometry [50].
To support the more specific molecular cloning of various env
domains, we modified these fluorescent reporter infectious
molecular clones by introducing a series of silent restriction sites
into env. These unique constructs support precise creation of
envelope chimeras, allowing for localization of Env-mediated
phenotypes to specific regions (ex. ectodomain), specific domains
(ex. V1–V5 loops) or precisely defined domains (ex. V3-loop). The
C2-V4 region contains the Env third variable loop (V3), a major
determinant of cell tropism, coreceptor usage, and transmission
[51–55]. Based on its important role in Env function, it is not
surprising that V3-loop polymorphisms have been associated with
changes in viral fitness, that antibodies targeting V3 can neutralize
viral infectivity, and that the V3-loop determines susceptibility to
entry inhibitors [28,56–59]. Previously, we showed that the V3-
loop sequences from a treatment naı¨ve, subtype C-infected, slow-
progressor, Zambian infant diverged extensively from birth to 67
months of age. Using viral isolates derived by co-culture,
divergence was correlated with an evolving Ab response that, at
each time-point, neutralized previous isolates but lacked efficacy
against the contemporaneous viral isolate [60].
Given the lack of a coreceptor switch or disease progression in
the infected child, we sought to define relationships between Env
C2–V4 sequence divergence, glycoprotein function, and viral
fitness. Patient sequences derived over a 67-month sampling
regimen were introduced into each of the HIV-1NL4-3 eGFP or
DsRed2 infectious molecular clones. The resulting virus prepara-
tions were subjected to competitive dual-infection matrices to
determine viral fitness of each C2-V4 allele relative to all others
from the same patient. To test for correlation of Env functional
parameters with fitness, the Env chimeras were then subjected to
biochemical characterization for Env synthesis and processing,
incorporation into virions, affinity for CD4 and CCR5, and RT-
normalized infectivity.
Here we demonstrate the utility of a modified system for
quantifying Env-mediated fitness, or replication capacity, where
patient-derived Env sequences can be directly cloned into
infectious molecular clone reporter viral constructs. In experi-
ments using subtype C Env C2-V4 sequences from an slow-
progressor child, we show the capacity to detect ‘winners’, ‘losers’,
and ‘ties’ in individual competitions, including detection of fitness
differences between extremely subtle polymorphisms. Aggregate
analysis of fitness/replication capacity associated with polymor-
phisms in the 1157i C2-V4 region of Env, supports a flat, but
rugged, fitness distribution indicative of mutational robustness.
Results
Construction and Characterization of HIV-1 NL4-3 MSS-
eGFP and -DsRed2 Infectious Molecular Clones
HIV-1 fitness has been studied previously using fluorescent
reporter HIV-1 vectors lacking either env or pol sequences that,
when linearized and co-transfected with patient-derived PCR
products, recombine to generate infectious chimeric virions. This
system offered substantial improvement over heteroduplex-based
fitness assessment regimens by supporting quantification of
outcomes at the single cell level using flow cytometry [45,61].
However, for our purposes, the method still suffered from
limitations. First, the production of viable progeny virions results
from inherently inefficient processes, co-transfection of a linearized
vector and a PCR product, followed by their subsequent
recombination. Second, the system only allowed for the insertion
of pre-defined patient env sequences since recombination requires
sequence homology between the linearized env-deleted vector and
the PCR product to be inserted. Moreover, almost any instance of
illegitimate recombination is likely to produce stop codons and
thereby non-infectious progeny, and, as we will show, even subtle
variations in amino acid sequence can have significant effects on
Fitness Relationships in HIV-1 Subtype C Env C2-V4
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Env mediated fitness. Therefore, it was important to be able to
define the junctions of the inserted sequence and the vector with
certainty. We further reasoned that it would be useful to have the
flexibility to concentrate on specific functional domains of env, or to
pursue a reductionist approach in analyses from a complete Env
sequence down to domains associated with particular phenotypes.
We used site-directed mutagenesis to introduce numerous silent
restriction sites into the HIV-1NL4-3 env gene. The result was
pNL4-3-MSS (Multi-Silent Site), which improved the flexibility
and efficiency of making Env-chimeras by creating a mechanism
to clone virtually any Env sequence (Fig. 1A). To capitalize on the
exceptional utility of the partial genome fluorescent reporter
vectors produced by Weber et al. [50], we transferred the
fluorescent reporter sequences from pNL4-3-Denv-eGFP and
pNL4-3-Denv-DsRed2 into pNL4-3-MSS to create pNL4-3-
MSS-eGFP and pNL4-3-MSS-DsRed2. Both infectious molecular
clone fluorescent constructs were sequenced to ensure there were
no unanticipated mutations (data not shown). Cells transfected
with pNL4-3-MSS-eGFP and pNL4-3-MSS-DsRed2 express the
respective fluorescent proteins from the HIV-1 LTR promoter
(Fig. 1B), providing a convenient evaluation of transfection
efficiency and a surrogate, in situ marker for HIV-1 gene
expression. To determine whether the constructs produced virus
particles, transfected cells were metabolically labeled, and
harvested supernatants were immunoprecipitated with polyclonal
anti-HIV-Ig. Bands consistent with gp120 (SU) and p66 (RT) were
detected by SDS-PAGE of viral pellets from the fluorescent vectors
as well as control non-fluorescent wild-type NL4-3 virus prepa-
rations (Fig. 1C).
The viral constructs make all viral proteins excepting Nef.
Contrary to a previous report [50], we found that while Nef was
detectable from a plasmid expression vector and two different
wild-type NL4-3 transfections, no expression of Nef was evident
from our fluorescent constructs (Fig. S1) or from the source
constructs for the fluorescent reporter genes, kindly provided
Miguel Quinones-Mateu. The likely explanation for this deficit is
that splicing is functioning efficiently to the reporter gene, but is
not supported to the nef exon. It is important to note that since the
constructs are isogenic other than the reporter genes, Nef is absent
from both constructs. Therefore, any potential effect lack of Nef
might exert on replicative capacity is controlled for in dual
infection competitions.
To verify that the viruses produced by transfection of pNL4-3-
MSS-eGFP and pNL4-3-MSS-DsRed2 are capable of mediating
multiple round infections, we harvested virus-containing superna-
tants from transfected HEK293T cells and used RT activity to
normalize the viral content. Constructs containing the wt NL4-3
Env sequence are exclusively CXCR4 tropic. We infected
U87.CD4.CXCR4 with equivalent units of RT activity and
monitored virus replication kinetics over the ensuing 12 days
(Fig. 1D). RT activity increased in supernatants from infected
cultures of both fluorescent viruses, demonstrating replication
competence. The maximum steepness of the sigmoidal curve for
eGFP virus was 6.28 CPM/day (90% CI 5.57–6.98), and for
DsRed2 virus - 6.93 CPM/day (90% CI 6.16–7.70). Fifty-percent
maximal accumulation of RT activity (RT50) occurred at
approximately Day 6 of culture for both constructs (eGFP virus:
6.20 days, DsRed2: 5.90 days). These values suggest the two
fluorescent viruses replicate with near identical replication kinetics
despite containing fluorescent reporter genes from two biolumi-
nescent species.
However, evaluating replication kinetics in parallel often fails to
detect differences in replication capacity when such differences
actually exist. Therefore, to directly and quantitatively test the
impact of the distinct reporter genes in the context of the wild-type
NL4-3 Env allele, dual-infection competitions between NL4-3-
MSS-eGFP and NL4-3-MSS-DsRed2, along with parallel control
mono-infections were set up on U87.CD4.CXCR4 cells at
multiplicity of infection (MOI) of 0.01, 0.1, and 1.0. Five days
post-infection, eGFP and DsRed2 signals were readily visible via
fluorescent microscopy (Fig. 2A) and infectious events were
quantified via flow cytometry. Comparable numbers of infectious
events were detected for each fluorescent virus at a given MOI
using the 561-nm laser for DsRed2 and 488-nm for eGFP
(Fig. 2B). We observed a dose-response relationship between the
two fluorescent viruses in mono-infections (Fig. 2B). Infections at
high MOI (1.0) were not analyzed due to extensive cell death in all
cultures, and the presence of dually-fluorescent (yellow), and
therefore dually-infected, cells in the competitive infections (data
not shown). We reasoned that such cultures could exhibit
phenotypes resulting from mixed genetics. No difference in fitness
between the two wild-type Env viruses in dual-infection compe-
titions was detected at a MOI of 0.1 or 0.01 (Fig. 2B) indicating
that neither fluorescent reporter gene imparted a significant gain
or loss of viral fitness. We were therefore confident that the distinct
fluorescent viral vectors would have the capacity to resolve subtle
fitness differences in competitive infections.
1157i C2-V4 Chimeras
As with other studies of HIV-1 transmission, our previous
findings suggested that restricted, or selective, transmission
occurred to 1157i. Previous genetic analyses of the C2-V4 region
of Env showed that diversification increased over the course of
infection. Divergence essentially paralleled diversification, and was
associated with accumulation of non-synonymous changes. Nev-
ertheless, tropism for CCR5 was maintained and neither sequence
length, or numbers of potential glycosylation, increased with time
[60]. The nucleotide changes/month as well as the amino acid
changes/month, for a minimum of 23 haplotypes/time-point, are
presented in Fig S2. Using co-cultured virus and patient sera, we
previously documented that de novo, as opposed to passively
acquired maternal, neutralizing responses were evident at 12
months, and from thence onward [60]. These humoral responses
appeared to correlate with ongoing Env diversification. Moreover,
comparative studies of Env diversification utilizing a pathogenic
simian-human immunodeficiency virus containing the 1157i
envelope sequence (SHIV-1157ipd3N4) have demonstrated com-
mon genetic patterns among two species of non-human primates
and the original infected infant [62,63]. One previous study
reported a positive correlation between temporal env C2-V3
diversification and viral fitness in Subtype B infected adult men
[48]. However 1157i is a drug-naı¨ve, slow-progressing infant
infected with subtype C HIV-1 in utero. Given that it was clear that
Env genotypically evolved in a temporal fashion in the patient and
in the two primate models, we asked how sequence evolution was
impacting the temporal fitness landscape in 1157i. Was Env-
mediated fitness increasing or decreasing with variation and
selection of C2-V4, or was the region simply undergoing variation
without impact on fitness?
Patient-derived C2-V4 HIV-1 env sequences were originally
amplified from genomic DNA for genetic characterization based
on sequencing and phylogenetics [60]. In the current study,
archival clones of these C2-V4 sequences in pGEM-T were
subjected to amplification with PCR primers that templated the 59
AgeI and 39 SbfI restriction sites compatible with NL4-3-MSS env to
generate cloneable env subgenic fragments (Fig. 1A). Twelve
individual env C2-V4 alleles were amplified from 0, 12, 18, 24, 36,
48 and 67-month pGEM-T constructs (Fig. S3). Alleles were
Fitness Relationships in HIV-1 Subtype C Env C2-V4
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selected on the basis of their genetic distance from one another
and proximity to the major phylogenetic branch of the subsequent
time-point.
Fitness Quantification in Primary CD4+ T Cells
Our data utilizing DsRed2 and eGFP infectious molecular
clones containing wild-type NL4-3 envelopes demonstrated
equivalent replication kinetics and fitness (Fig. 1d & 2b).
Sequence analysis of 1157i C2-V4 alleles revealed only a single
Ser/Thr polymorphism in a sequon at position 227, (Fig. S3)
between date-of-birth samples 00m06 and 00m15. Viral stocks of
chimeras 00m06 (eGFP) and 00m15 (DsRed2) were generated by
transfection of HEK293T cells. We anticipated that competitions
between these nearly identical chimeras would produce neutral
fitness outcomes. To quantify fitness of these initial chimeras,
stimulated CD4+ T-cells were isolated by negative immunomag-
netic sorting from three genetically distinct blood donors. The
enriched CD4+ populations were infected at an MOI of 10 in
mono- and dual-infections, a multiplicity sufficient to ensure
production of fluorescent cells for fitness calculations without
Figure 1. Expression of infectious molecular clones results in fluorescence in 293T transfectants and generation of infectious
virions. a) Diagram of the HIV-1 NL4-3-MSS-eGFP/DsRED2 construct showing an expansion of the region bounded by EcoRI and XhoI and
encompassing the code for Tat, Vpu, Rev, and Env. Introduced silent mutations are underlined. Sequence region utilized in this paper purple. b) HEK
293 cells transfected with either NL4-3-MSS-eGFP or NL4-3-MSS-DsRED2 were imaged by fluorescent microscopy (406) at 48-hours post-transfection
(b). c) Pelleted virions derived from 35S- radiolabeled transfected cells were immunoprecipitated with HIV-Ig and the resulting proteins were
separated by SDS-PAGE revealing bands corresponding to gp120 (Env) and p66 (RT) in wild-type, NL4-3-MSS-eGFP, and NL4-3-MSS-DsRED2, but not
mock transfected cells. d) Virus stocks derived from NL4-3-MSS-eGFP (green line) and NL4-3-MSS-DsRED2 (red line) transfections were used to infect
U87.CD4.CXCR4 cells. Virus replication kinetics were assayed using a 3H-based RT assay at the indicated time-points. Mock transfected cell
supernatant served as a control (black triangles).
doi:10.1371/journal.pone.0063094.g001
Fitness Relationships in HIV-1 Subtype C Env C2-V4
PLOS ONE | www.plosone.org 4 April 2013 | Volume 8 | Issue 4 | e63094
generation of co-infected cells (dually fluorescent). Independent
infections were assayed by flow cytometry in triplicate on days 3–7
to quantify eGFP and DsRed2 positive cells for calculation of
relative fitness (W) values for the 00m06 and 00m15 C2-V4 alleles
(Fig. 3a). Fitness is calculated by quantifying the change in the
proportion of each competitor (infectious events) in the dual-
infection to the quantity of infectious events in matched mono-
infections, which act as internal controls. On this fitness coordinate
system, maximum fitness or competitiveness is 2.0, whereas total
lack of fitness is 0.0, and neutrality is at 1.0. We were surprised to
find that competitions between 00m06 and 00m15 alleles resulted
in significant fitness differences at the endpoint (7 days post-
infection). Initial proportions of infected cells from the dual-
infection suggested that 00m15 was less fit than 00m06 (Day 3, W
00m15DsRed2 = 0.819760.1321) (Fig. 3a, b). However, 00m15
fitness value steadily increased over the course of 7 days indicating
that the initial findings resulted from titer underestimations for the
innocula used to set up the dual- infection that required 00m15 to
undergo multiple rounds of replication in both the mono- and
dual-infections before demonstrating competitive exclusion. The
increase in 00m15 fitness occurred in all blood donors, and there
was no difference in the slope of the increase in fitness in the three
donors. When the mean fitness value from all three donors was
plotted over time, at Day 7, 00m15 was more fit than 00m06 (W
00m15DsRed2 = 1.422 vs. W 00m06eGFP = 0.57860.1094)
(Fig. 3b). These data, from viruses differing by a single, seemingly
conservative, point mutation in a maintained N-linked glycosyl-
ation motif, demonstrate that this fitness quantification platform is
potentially more sensitive than those previously reported.
Fitness Quantification in U87.CD4.CCR5 Cells
The number of dual infections and controls required to analyze
fitness for all chimeras precluded the use of primary cells as targets
for infection. Moreover, though we saw no differences between the
relative fitness values calculated from three different blood donors,
the use of a defined cell line, such as U87.CD4.CCR5, previously
utilized for competition assays, would simplify the assay in terms of
time and cost as well as reducing the potential introduction of
donor-specific effects, such as variation in receptor/coreceptor
expression levels [46]. U87.CD4.CCR5 cells were infected at an
MOI of 0.1 to determine whether they recapitulated fitness
outcomes in PBMC. By Day 5, both the 00m06 (eGFP) versus
00m15 (DsRed2) and the reciprocal infections, 00m06 (DsRed2)
versus 00m15 (eGFP) reproduced the same fitness relationships
determined in PBMC (W 00m15DsRed2 = 1.21360.07732,
00m15eGFP 1.38660.1659) (Fig. 3c). Competitions in
U87.CD4.CCR5 using independently generated and titered viral
stocks not only recapitulated outcomes from PBMC dual-
infections, but did so in a shorter amount of time and at a lower
MOI. Therefore, subsequent analyses were carried out in
U87.CD4.CCR5 at Day 5 to ensure that infectious events were
readily detectable, and that the more competitive variant had not
competitively excluded the less fit variant to the point of
extinction.
Virus stocks for all chimeras were produced by transfection of
HEK293T cells, titered and subjected to triplicate, dual-infection
competitions versus all other chimeras in the opposite color vector,
including itself. Each chimera was also introduced into the
alternative fluorescent vector and subjected to reciprocal compe-
titions. Relative fitness (W) values for each competition were
determined in comparison to parallel mono-infections with each
chimera at the same MOI. The self-self competitions, which are
theoretically anticipated to be 1.0, were not experimentally exactly
1.0. An example competition, where the DsRed2 and eGFP
fluorescent reporter viruses both contain the C2-V4 sequence
haplotype 15 from 67 months post-infection (67m15), is shown in
Figure 4A. This example demonstrates the anticipated outcome
that is competitions of the same Env sequence against itself results
in a neutral outcome W ,1.0 (0.9960.31). While all competitions
performed at the same time with the same stocks of virus were
comparable to one another, to support comparison between all
chimeric competition sets, all other competitions in each data set
were adjusted to reflect the deviation between theoretical (1.0) and
actual values for the self-self competitions. For example, 67m14
self-competitions resulted in a W of 1.1360.29 (n = 3, 6 SD),
slightly higher than the expected 1.0. To adjust the values to 1.0,
Figure 2. Infectious molecular clones express fluorescent protein reporter upon infection of target cells. a) U87.CD4.CXCR4 cells were
infected at a MOI of 0.1 with NL4-3-MSS-eGFP, NL4-3-MSS-DsRED2, or both viral variants. Five days post-infection, cells were imaged by fluorescent
microscopy (406). b) Fluorescent events from mono- and dual-infection of U87.CD4.CXCR4 cells at MOI of 0.1 and 0.01 were enumerated by flow
cytometry. Fluorescent cells were quantified on an Influx cell sorter, excitation 488-nm (eGFP) and 561-nm (DsRed2). MOI of 1.0 was not quantified
due cell death in mono- and dual-infections, as well as the presence of dually infected cells (double positive ‘yellow’ cells).
doi:10.1371/journal.pone.0063094.g002
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the self-values were multiplied by a factor of 0.927, thus the
adjusted W was 1.0560.27. Similar adjustments for self-self
variation were carried out for all chimera competition sets. All self-
self competitions had a mean of 1.03 (95% CI 0.98–1.1), which
was not statistically different from 1.0 (One sample t test).
When chimeras were individually analyzed, we identified env-
chimeras that were consistently less competitive, W,1.0, (Losers);
whereas other env sequences imparted a more competitive
phenotype W .1.0 (Winners). Disparate fitness phenotypes were
quantified among env sequences isolated at the same time-point
(Fig. 3 & 4B, C). Thus the fitness assay readily discriminates env
C2-V4 sequences that impart greater or lesser fitness on a
common viral genetic background, and can do so within the
spectrum of polymorphisms contained within a single individual or
within a single time-point of collection.
Aggregate analyses of relative fitness values from all competi-
tions (n = 396 dual infections, associated eGFP and DsRed2 mono-
infections, and mock infections) are presented in Fig. 5, with
circles representing individual data points, black bars representing
means, and error bars representing 95% CI (numeric data Table
S1, individual competitions Fig. S4). In individual competitions
between chimeras (Fig. S4), we observed a wide range of W values
demonstrating that the system has discriminatory capacity to
segregate winners and losers in individual competitions
(range = 0.23–2.0). With the exception of 12m04 and 67m15, all
average fitness values were significantly different from neutrality
(95% CI), suggestive of a rugged fitness landscape (Table S1).
From Figure 5 & Table S1, it is also clear that there were
chimeras that were significantly more fit than others (e.g. 36m29).
Equally, there were those that were significantly and consistently,
less fit (e.g. 00m06). In many cases, however, relative fitness values
were statistically indifferentiable from one another (Table S3).
Taken together, the samples of C2-V4 sequences derived from this
infected individual imparted average viral fitness values that
clustered about neutrality (Range: 0.65–1.24, Mean: 0.97,
Median: 0.96) (Fig. 5– black bars). While diversification and
divergence were increasing with time in this region of Env, no
statistically significant temporal trend in fitness outcomes could be
detected.
In an effort to detect temporal fitness trends in C2-V4 we
combined the outcomes of all fitness competitions into categories
based on allele isolation time-point (e.g. data from 00m06 and
00m15 were combined into a 00m data set). Analysis of the
temporally grouped competition data sets resulted in a linear
regression slope that was not statistically differentiable from zero,
supporting the concept of a flat fitness trajectory over time (data
Figure 3. Chimera fitness in PBMC and U87.CD4.CCR5 cells. a) Stimulated CD4+ T-cells isolated from three genetically distinct blood donors
were infected with chimeric viruses generated from patient viral sequences isolated at birth, NL4-3-00m06-eGFP and NL4-3-00m15-DsRED2. Infected
cells were quantified by flow cytometry to calculate relative fitness (W) on days 3–7 post-infection. W of NL4-3-00m15-DsRED2 shown. b) Mean NL4-
3-00m15-DsRED2 W from each donor (dots) with standard deviation (bars) over time. c) Competitions between NL4-3-00m06-eGFP and NL4-3-
00m15-DsRED2 and the reciprocal NL4-3-00m06-DsRed2 and NL4-3-00m15-eGFP were repeated in U87.CD4.CCR5 cells. In both competitions, the W
of NL4-3-00m15 in U87.CD4.CCR5 at Day 5 post-infection was not statistically different from the W calculated in PBMC at Day 7.
doi:10.1371/journal.pone.0063094.g003
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not shown). These data suggest the fitness distribution between
time-points needs to be sampled at a greater depth, and that more
env sequences from more patients with different courses of disease
need to be longitudinally analyzed using this method to determine
whether evolutionary trajectories are evident.
Biochemical Characterization of 1157 V3-loop Chimeras
The HIV-1 envelope glycoprotein carries out several essential
processes in HIV-1 replication that can be individually quantified.
Given the lack of a clear temporal relationship with fitness we
sought to investigate how viral fitness associated with biological
functions of Env. We tested for relationships between fitness and
parameters of Env function, including synthesis and processing of
gp160, incorporation of Env trimers into virions, Env affinity for
CD4 and CCR5, and single-round virus entry.
Env Synthesis, Processing, and Virion Incorporation
Using metabolic labeling and immunoprecipitation, followed by
quantification of signal using a phosphorimager, we observed
differences between chimeras in the rate of change of the
gp120:gp160 ratio (i.e. the processing of gp160 into gp120) over
the course of a 24-hour chase (range of slopes = 0.0035–0.027
DLU/hour) (Fig. 6A). Despite these differences, the efficiency of
processing did not correlate with average fitness values (Fig. 6B).
However, when the level of gp120 incorporated into pelleted
virions, relative to p66 RT, was investigated (Fig. 6C), there was a
modest correlation with average fitness values (R2 = 0.43)
(Fig. 6D). This suggested that perhaps quantity, rather than
quality of Env was playing a role in determining fitness. However,
despite obvious differences in levels of Env synthesis and
processing as well as the efficiency with which Env was
incorporated, neither biosynthetic parameter appeared solely
predictive of Env-mediated fitness.
Viral Entry
As anticipated from previous publications [45,46], there was a
positive trend between Env-mediated infectivity (Fig. 7A) and
average relative fitness values (Fig. 7B). However, this trend
exhibited only a moderate correlation (R2 = 0.44), with two data
points falling outside of the 95% confidence range. This indicates
Figure 4. Results from individual patient chimera competitions. a) U87.CD4.CCR5 cells were infected with NL4-3-67m15-eGFP, NL4-3-67m15-
DsRED2 at a MOI of 0.1 in mono- and dual-infections. The numbers of fluorescent events were enumerated by flow cytometry. The numbers of events
were then used to calculate relative fitness (W) values. This process was carried out for all competitions, in triplicate. b) The resulting W values from all
NL4-3-00m06-DsRED2 vs. all other viruses in eGFP, and c) NL4-3-00m15-DsRED2 vs. all other viruses in eGFP. Circles represent individual W values,
black bars represent means, and error bars represent standard deviation. Results from all chimeras in Fig. S4.
doi:10.1371/journal.pone.0063094.g004
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that while there may be a relationship between Env, infectivity,
and viral fitness, one cannot confidently predict the relative fitness
of a virus from normalized single-round infectivity results. This is
especially true with small sample sizes typical of experiments with
human samples. The correlation was lost when co-adjusted for the
level of Env incorporation into particles [infectivity (DLU)/p66)/
incorporation (Env/p66)] (R2 = 0.11), again suggesting that the
fitness trend associated with Env was influenced by the quantity of
Env on the surface of virions, rather that the functional quality of
individual Env chimeras (Fig. 7C–D). Together, these results
suggest that fitness imparted by Env might be more a function of
avidity, resulting from multivalent low affinity interaction between
Env and the target, than from high affinity, but low abundance,
interactions.
Receptor and Coreceptor Affinities
To begin to test relationships between avidity or affinity and
fitness, we next evaluated parameters associated with viral entry
into a new host cell for their correlation with fitness. Affinity of
each chimeric Env for the primary receptor, CD4, was assayed
via competition with the anti-CD4 antibody B4 for available
receptors on TZM-bl cells (Fig. 8A). The introduction of the
subtype C C2-V4 sequences converted NL4-3 from exclusive
X4 tropism to R5 tropism. Therefore, CCR5 coreceptor affinity
was assayed by competition with antibody 2D7 (Fig. 8B).
Despite a wide range of phenotypes (IC50 = 0.083–0.85 mg/ml
B4, IC50 = 0.0079–0.21 mg/ml 2D7), there was no correlation
between affinity for CD4 or CCR5 and fitness (Fig. 8C-D). In
sum, the biochemical quantifications of Env function suggest
that relative fitness values are determined by quantity of Env in
particles, rather than the affinity of Env for relevant cellular
receptors.
Discussion
Dual-infection Competitions and Limitations of Current
Methods
Links between HIV-1 fitness and disease progression, virus
transmission, drug resistance, immune escape, and global epide-
miology have been experimentally established. Because of these
associations, numerous assays have previously been developed for
measuring HIV-1 fitness in vitro [24,26,47,64–69]. Large differ-
ences in fitness can be identified via differential viral growth
kinetics [15]. However, these approaches are often incapable of
elucidating subtle fitness differences between HIV-1 variants as
might be anticipated to exist in genetically related viruses derived
from a patient over the course of infection, or in samples from a
quasispecies at a single time-point [15,45,46,48].
When two or more variants are in competition with one
another, the ‘more fit’ variant will eventually outgrow ‘less fit’
variants by competitive exclusion i.e. ‘survival of the fittest’ as
resources become limiting [3,70–72]. In the absence of gross
replicative defects, two HIV-1 variants can have virtually
identical in vitro growth kinetics, yet disparate fitness values in
Figure 5. Aggregate data from all patient chimera competitions. Each C2-V4 patient chimera (DsRed2) was competed against all others
(eGFP) in triplicate. WRED was calculated for each competition, and plotted in aggregate for each chimera. Black bars represent mean, and 95% CI.
doi:10.1371/journal.pone.0063094.g005
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competition with one another [46]. Viral fitness is therefore
optimally defined by assaying replication where viruses are
competing in an identical environment (dual-infection), and
where the performance in the dual-infection can be directly
normalized to the replication of each competitor in monoinfec-
tions innoculated with the same quantity of virus [49]. In
addition to providing a standard for determining proportional
changes in viral species in competition, mono-infection controls
eliminate concern about the absolute equality of the titers of the
two species at the beginning of the competitions.
Heteroduplex tracking assays (HTA) or qRT-PCR have
previously been used to quantify HIV-1 fitness in dual-infection
competitions among viruses in HIV-1 panels [45,48,73,74]. One
of the striking findings was that HIV-1 fitness, in the absence of
treatment, is a function of the envelope glycoprotein [46]. While
previous methods to quantify fitness have proven unquestionably
useful, they are limited by inability to discriminate variants with
either too much or too little genetic diversity within the detection
target sequence. Likewise, recent methods employing precise
parallel allele-specific sequencing have the advantage of precise
quantification of fitness differences but require prior knowledge of
the sequences under selection as well as specialized instrumenta-
tion and expertise [75].
Advantages of the New Vectors for Fitness Analyses and
Other Applications
The infectious molecular clones we describe here contain either
the eGFP or DsRed2 fluorescent reporter gene, and, being derived
from a previously validated fitness analysis system, provided a
simple and direct platform for quantifying Env effects on HIV-1
fitness. A primary advantage of our system over other HIV-1
fluorescent reporter vectors [50] is the inclusion of sites to facilitate
precise molecular cloning of env genes or subdomains (Fig. 1A).
The fluorescent signal produced upon viral infection supports
quantification of infectious events in dual-infection competitions
by universally accessible methods (flow cytometry or qRT-PCR),
which in turn, allows for the calculation of relative fitness values.
Because the fluorescent reporter is contained within the viral
genome, the resulting viruses can be used to quantify infectivity of
patient Envs on any target cell type, including primary cells
(Fig. 3).
These constructs have additional applications. First, co-infected
cells skew interpretation of fitness assays due to the capacity for
recombination between the competing strains [76,77]. A substan-
tial benefit of using eGFP and DsRed2 reporters is that they
provide the ability to detect co-infected cells (‘yellow’ fluorescence),
resulting from high MOI infections. Moreover, since the eGFP
and DsRed2 genes are derived from different species (the jellyfish
Figure 6. Patient chimeras differ in Env processing and incorporation. a) 293T cells were transfected with patient eGFP chimeras. 24-hours
post-transfection, cells were radiolabeled with 35S. Cells were lysed at the indicated time-points, immunoprecipitated with HIV-Ig, and resolved by
SDS-PAGE in order to quantify the processing of gp160 and accumulation of gp120. To quantify the processing of Env, the slope of the ratio of gp120
to gp160 verses time was calculated for each chimera (00m06, 00m15, 12m04 shown). b) Slope values were plotted against average relative fitness
values to determine correlation (dashed lines 95% CI). c) Supernatants from radiolabeled 293T patient eGFP chimeras’ transfections were pelleted,
lysed, and immunoprecipitated with HIV-Ig. SDS-PAGE was used to resolve gp120 and p66 protein bands for calculating incorporation of Env relative
to wild-type virus, in triplicate. d) This ratio was plotted against relative fitness values, and revealed a modest positive correlation (R2 = 0.4349)
(dashed lines 95% CI).
doi:10.1371/journal.pone.0063094.g006
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Aequorea victoria versus the sea anemone Discosoma striata) [78,79],
they are less likely to undergo recombination. Given the MOI we
employed, we rarely detected yellow, co-infected cells at the
endpoint analysis, and when they were detected, the dual-infection
competitions were repeated at reduced MOI. On the other hand,
our system readily supports the identification, and cell sorting, of
co-infected cells that could be used to investigate the biology
associated with HIV-1 recombination.
In addition, minimal spectral overlap in the excitation and
emission of eGFP and DsRed2 (excitation 488-nm and 531-nm,
emission 509 nm and 582 nm, respectively), limits the need for
compensation adjustments and simplifies data acquisition and
analysis by flow cytometry. Dual-infection competitions can also
be readily quantified via qRT-PCR using amplicons directed
against the distinct fluorescent reporters due to their lack of
sequence homology [78,79]. Using this approach, entire collec-
tions of env chimeras could be detected with the same optimized
primer-probes, rather than requiring discrete reagent sets for each
individual allele. We have shown that qRT-PCR amplicons
directed towards the fluorescent genes have virtually no cross-
reactivity towards the other template (Fig. S6), making them ideal
multiplex RT-PCR targets. Furthermore, as measuring fluores-
cence in situ does not require cell lysis, given cell-sorting capacity in
biocontainment, these fluorescent markers support live sorting of
infected cells for use in any number of downstream applications.
For example, the constructs may prove useful for screening
neutralizing antibodies where the restriction sites allow for the
introduction of a complete Env ectodomain that could be followed
by reductive introductions of smaller sequences to localize Ab
binding.
Longitudinal Ab-driven Divergence of C2-V4 in 1157i
We chose to demonstrate the utility of our system using
genetically characterized Env C2-V4 sequences derived longitu-
dinally from a slow-progressing, subtype C HIV-1 -infected,
Zambian patient, 1157i. We selected this panel of Env variants for
four reasons: 1) because longitudinal variants from a single infant
had not been previously evaluated for differences in Env-mediated
fitness by dual-infection competition, 2) because we reasoned that
these isolates would test the capacity of the assay system to
quantify fitness values among closely related sequences, 3)
phylogenetic analyses of Env C2-V4 suggested that env diversifi-
cation was taking place at both the nucleotide and amino acid level
(slope = 0.25 nucleotide differences/month, 0.18 amino acid
differences/month Fig. S2) moreover, positive selection was
taking place since increases in non-synonymous changes (dN/dS)
over time were detected [60], and 4) immunological assessment of
1157i plasma samples suggested that NAb were exerting selective
pressure on Env, since sera collected at later time-points were
capable of neutralizing viruses isolated at earlier time-points, but
minimally neutralized contemporary viruses. [80]. Collectively
these previous analyses suggested that diversification within 1157i
env had taken place in response to humoral immune pressure.
Figure 7. Chimera infectivity has a modest correlation with fitness, while infectivity per incorporated Env does not. a) Infectivity of
each chimera was assayed via luciferase activity of TZM-bl cells (Relative Light Units, RLU), relative to p66, as determined by immunoprecipitation of
radiolabeled virions (see Fig. 5c), relative to wild-type NL4-3, in triplicate. b) The average infectivity value was plotted against average relative fitness
values, and revealed a modest correlation (R2 = 0.4448) (dashed lines 95% CI). c) The ratio of average infectivity to average incorporation of Env was
calculated to determine average infectivity per incorporated Env. d) When this ratio was plotted verses average relative fitness values, there was no
correlation (R2 = 0.1058) (dashed lines 95% CI).
doi:10.1371/journal.pone.0063094.g007
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Subtle 1157i C2-V4 Variants from the Date of Birth Exhibit
Fitness Differences
The C2-V4 region of Env plays a critical role in viral tropism
and transmission, as well containing a principal neutralization
determinant, the V3-loop [55,81]. To investigate relationships
between viral fitness and sequence diversification in C2-V4, viral
chimeras were created by introducing 1157i C2-V4 sequences,
isolated from birth to 67 months, into the NL4-3-MSS-eGFP and
DsRed2 vectors. Though this region underwent genetic diversifi-
cation over time in 1157i (without alteration of coreceptor usage),
C2-V4 sequences obtained at birth (00m06, 00m15) were virtually
identical (Fig. S3). This limited DNA diversity only manifested in
a single amino acid difference, a Ser or Thr at amino acid 227 in
the third position of a potential N-glycosylation site. With such
limited amino acid differences between the two variants, one
would anticipate that both variants would have similar relative
fitness values. However, 00m15 (Thr227) proved to be more fit
than 00m06 (Ser227) in CD4
+ T-cells isolated from three different
blood donors and in U87.CD4.CCR5 cells (Fig. 3). We
hypothesize that threonine supports preferential glycosylation
[82], or perhaps the differential glycan addition to the associated
Asn. The resulting altered Env structure and function, thereby
contributes to the fitness differential [82]. It is also conceivable that
one or the other sequon variants is simply not recognized as a site
for glycan addition in the Env folding pathway within the ER.
This in vitro fitness advantage of 00m15 appears to correlate with
an in vivo fitness advantage, since the ‘more-fit’ Thr polymorphism
was maintained at subsequent time-points. Maintenance of Thr is
also consistent with its approximately 2-fold preferential utilization
in N-linked glycosylation motifs [82]. The outcomes of competi-
tions between 00m06 and 00m15 chimeras highlight several
important points: 1) though in vitro fitness assays cannot perfectly
mirror the selective environment occurring in a patient, our
observations demonstrate that in vitro fitness assays yield biologi-
cally relevant information, 2) the competition system has the
ability to reproducibly differentiate between fitness ‘winners’ and
Figure 8. Chimera affinity for CD4 or CCR5 is not correlated with fitness. Viral stocks of eGFP chimeras were incubated with serial dilutions
of a CD4 competitor (B4 Ab) or CCR5 competitor (2D7 Ab), and added to TZB-bl indicator cells. Though reduction in eGFP expression with increased
competitor antibody could be visualized via microscopy (a, b) (406), IC50s were calculated from luciferase activity assays, in triplicate. When IC50
values were plotted against average relative fitness values, there was no correlation for CD4 affinity (c) (R2 = 0.02970) or (d) CCR5 affinity
(R2 = 0.0001508) (dashed lines 95% CI).
doi:10.1371/journal.pone.0063094.g008
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‘losers’ in primary CD4+ T-cells as well as U87 cell lines, 3) fitness
differentials can be identified even when the sequences in question
differ by extremely subtle polymorphisms, 4) such information
could inform further study of envelope structure and function in
relation to viral fitness or other parameters.
C2-V4 Variants from Later Time-points Suggest
Increasingly Complex Fitness Relationships
U87.CD4.CCR5 cells were used for dual-infection competitions
pitting each chimeric Env virus against all others, in what was
essentially a viral ‘round-robin’ tournament. This cell line was
utilized in lieu of PBMC because of the substantial number of
competitions and controls for fitness analysis in this study, and
because the U87.CD4.CCR5 cell line has been used in previous
fitness analyses [46]. We showed that it not only reproduced
PBMC outcomes, but did so with less virus (lower MOI) in a
shorter amount of time (Fig. 3). Relative fitness values from each
individual competition were calculated and ranged between 0.23-
2.00 (Table S1).
When analyzed individually and in aggregate, head-to-head
competitions yielded complex findings. Though we compared
sequences from a relatively small region of Env, derived from the
same patient and from within time-points, identifying molecular
determinants of fitness was not as simple as identifying ‘more-fit’
and ‘less-fit’ amino acids at set locations. Shared polymorphisms
could be associated with a ‘more-fit’, ‘less-fit’, or ‘neutral’ outcome,
depending on their context with other polymorphisms within a
given allele. For example, 12-month time-point sequences, 12m04
and 12m22, like those from 00m, differed from one another by a
single amino acid that resulted in loss or retention of a putative
glycosylation site (N or S at amino acid 329 Fig. S3). This
polymorphism did not have an effect on viral fitness in head-to-
head competitions, nor was there a statistical difference between
12m04 and 12m22 average relative fitness values (Fig. 5, Fig. S4,
Table S2). Based on our finding that 12m22 had a neutral or less
fit outcome in average relative fitness values versus eleven other
alleles, and the fact that, S329 was not maintained in subsequent
time-points makes it attractive to conclude that S329 was not a
fitness-favorable polymorphism. However, the exception appeared
at the 48-month time-point, with 48m11 containing N329 and
48m12 the S329. Despite an additional 26 polymorphisms between
48m11 and 48m12, these two viruses were neutral in head-to-head
fitness, and did not have significantly different average fitness
values (Fig. 5, Fig. S4, Table S2). However, the additional 17
polymorphisms between 12m22 and 48m12, both of which
contain the Ser329, lead to 48m12 being more fit in both head-
to-head and total average fitness. In fact, the S329 containing
48m12 had significantly higher average fitness values than 5 of the
other 11 variants, but was not detected at 67m. The genetics of the
subsequent time-point along with our fitness results, lead us to
hypothesize that the S329 is either a minor variant, a neutral
polymorphism in this context, or it is actively negatively selected
against by a factor not directly measured (i.e. antibody selection).
In the future, resolving the complexity in the relationships between
genetic polymorphisms and fitness outcomes would require more
thorough sampling at a given time-point as well as comparison to
both prior and subsequent time-point allele frequencies and
associated fitness values.
Our results also highlight a benefit to competing all viruses
against one another, as opposed to competing the chimeras against
reference strains. A viral ‘round robin’ does not assume that 1) all
fitness results are transitive (a.b, b.c, therefore a.c), or 2) all
fitness results are cumulative (a.b by 0.1, b.c by 0.1, therefore
a.c by 0.2). While these assumptions might be valid in some
circumstances, they would have been incorrect assumptions for
this study. For example, chimeras 12m04 and 18m33 were
approximately neutral in head-to-head competition with one
another (Fig. S4) (12m04DsRed2 vs. 18m33eGFP = 0.9560.13,
12m04eGFP vs. 18m33DsRed2 = 1.060.06), and their average
relative fitness values were not statistically different (Table S2).
Competition against reference strains would assume that these
chimeras would fare similarly against others, winning, losing, and
tying against the same viruses by the same magnitude. That was
not the case. Chimera 12m04 had a statistically higher average
relative fitness than 00m06, but lower than 36m29. Average
relative fitness of 18m33 was lower than 00m15, 36m29, 48m11,
48m12, and 67m14 (Table S2). So while the amino acid variation
between 12m04 and 18m33 appeared to have no impact on viral
fitness in head-to-head competition, the true impact of that
variation became apparent when the viruses were competed
against other alleles. The ‘round robin’ strategy made possible by
our competition system allowed us to elucidate an enriched fitness
landscape that would have remained hidden had reference strains
been used.
Extinction was not Observed
Fitness competition data was further analyzed by grouping all
competition outcomes for each chimera. Previous fitness analyses,
particularly those between subtype B and C, revealed substantial
disparities in replicative fitness between subtypes. In those
instances, it was necessary to dilute ‘more-fit’ subtype B variants
by orders of magnitude to prevent complete exclusion of the ‘less-
fit’ subtype C variant [45]. Dilutions were not necessary for the
competitions in this study, as no variant was grossly more or less fit
than the others over the time course of the analysis. This is likely
because all variants were derived from a single individual. An
alternative reason could be that no critical Env fitness determi-
nants lie inside the C2-V4 region of Env. The latter explanation is
not supported by data from previous studies that have demon-
strated the essential nature of the V3-loop [28,51–59]. Our data
shows that competitive exclusion is taking place and that given
sufficient time, extinction would occur (Fig. 3). However, allowing
such complete exclusion reduces complex fitness assays from
quantitative measures to less informational binary results.
Potential Relationships between Humoral Responses and
Fitness Outcomes
While there were statistically significant differences between
average relative fitness values, none of the chimeras were a
universal ‘winner’ or ‘loser’. The values clustered between 0.65
and 1.23, suggesting that in spite of sequence diversity in C2-V4,
the chimeras have similar average fitness (Table S1–S2). Our
previous neutralization analyses with 1157i revealed an evolving
humoral neutralizing response that acted against previous viral
isolates but not against contemporaneous isolates. That is, 48m
sera neutralized virus co-cultured from all previous time-points but
had little impact on the 48m or subsequent 67m isolate. Those
results along with the increases in nonsynonymous changes in C2-
V4 implied the host antibody response was acting to select the viral
population in this region of Env. Plasma samples from 1157i were
exhausted in previous analyses [60]. Thus, we were unable to
directly assess relationships between replication competitiveness
and neutralization sensitivity of chimeric Env alleles. As such, our
results represent quantification of differential replication capacity
in the absence of demonstrable selection.
However, in the Amsterdam cohort of HIV-1 subtype B
infected adults, the impact of neutralizing antibody, and even
broadly neutralizing Ab on autologous virus growth kinetics, as a
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surrogate for fitness, was tested. No inverse relationship between
fitness and neutralization Ab titer or breadth was reported [83,84].
Similarly, Troyer et al. demonstrated that Env CTL escape
variants suffered a fitness deficit less frequently than escape
variants in other structural genes [85]. And, mutations in Env that
block recognition by NAb have also been shown to have little
impact on viral fitness [83,84]. Recent findings have suggested that
broadly neutralizing antibodies may select Env quasipecies
resulting in reduced viral fitness [75,86,87]. These effects appear
to be temporary since viral load in many cases appears to rebound
[86].
We have no evidence that 1157i possessed bNAb and given the
time post-infection required to develop bNAb responses, it seems
unlikely [88]. But it is reasonable to speculate that neutralizing
antibodies with more restricted breadth have less impact on fitness
than do bNAb, resulting in a pattern similar to that observed in
1157i. This concept requires further experimental validation but
can be inferred from the finding that only some of the escape
variants generated in early infection undergo a fitness deficit as a
result of humoral selection [87]. Collectively, published data, and
that from the current study, suggests that HIV-1 Env, tolerates
mutation leading to immunological escape while maintaining
protein functionality and viral fitness or replication capacity at
adequate levels.
Env Quantity/avidity Measures Trend Most Closely with
HIV-1 Fitness
In an effort to understand how fitness is maintained in the face
of genetic diversification, we biochemically characterized the
functions of Env in the HIV-1 replication cycle, including synthesis
and processing, incorporation into virions, affinity for CD4 and
CCR5, and infectivity. As expected from previous reports,
infectivity did positively trend with average fitness values [73].
However, infectivity was not statistically useful for predicting
relative fitness (R2 = 0.44) (Fig. 7B), similar to what others have
recently reported [75]. Similarly, incorporation of Env into virions
contributed to viral fitness since a positive trend between
incorporation and relative fitness (R2 = 0.43) was detected
(Fig. 6D), a weak correlation previously described by others
[43]. Again, however, incorporation levels are not a useful proxy
assay for estimating fitness, as other studies have not found
statistically significant differences in Env incorporation levels in
pseudoviruses generated from elite suppressors and chronic
progressors [89]. The ratio of infectivity per Env ((Infectivity/
p66)/(Env/p66)) could be considered the efficiency of a given
quanta of Env to support entry. This ratio, however, was not
correlated with average fitness (R2 = 0.10) (Fig. 7D).
Interestingly, several chimeras contained polymorphisms in
putative CD4 contact residues in C2 and C3, which have
previously been associated with higher or lower CD4 affinity
[90]. Yet despite the finding that chimeras exhibited a wide range
of affinities for CD4 (B4 IC50 0.083–0.85 mg/ml), and CCR5 (2D7
IC50 0.0079–0.21 mg/ml), neither receptor binding parameter
correlated with average fitness (R2 = 0.033, 0.00035 respectively)
(Fig. 8C-D). This suggests that while there clearly must be some
affinity between Env and CD4 as well as with coreceptor, a range
of affinities can be tolerated without adversely effecting viral
fitness. Collectively, these results support the conclusion that it is
Env quantity, and perhaps avidity, rather than affinity that most
potently influences virus entry and therefore fitness.
In the correlations between biochemical assays and fitness, no
chimera was consistently an outlying data point, above or below
the 95% CI. No chimera was shown to consistently over- or under-
perform and skew the correlations. One interpretation of these
data is that there are multiple pathways to maintaining fitness
adequacy in the Env-mediated HIV-1 entry pathway. An
examination of functional assay outliers highlights this basis of
this concept. For example, 36m29 and 48m12 both had similar
fitness values statistically greater than 1.0. In functional assays,
however, these chimeras demonstrated distinct biochemical
properties, including viral entry (Fig. 5 & 7). Previous studies
investigating the biochemical properties of transmitted Env
variants determined a wide range of phenotypes [91]. Likewise,
our results suggest that fitness, while determined by the HIV-1
entry process, is defined by the sum of the efficiencies with which
Env is able to accomplish each step, suggesting that no single
readout is likely to satisfactorily correlate with fitness. It also
implies that each parameter assayed makes an important, but not
necessarily equal, contribution to the entry process and therefore
to fitness. Thus, no functional assay is able to serve as a proxy
measure for fitness.
Env C2-V4 Fitness Landscapes and Population Biology
Concepts
Population biology has supported the concept of ‘‘survival of the
fittest’’ suggesting that natural selection favors the propagation of
genomes that impart a pinnacle of fitness to the organism (fitness
peaks) and deviation from those sequences results in a drop in
overall fitness (fitness valleys). In such a model, populations with
high mutation rates, such as retroviruses, would lack the capacity
to maintain genome integrity should they reach a fitness peak, and
therefore would fall into a valley. Alternatively, a ‘flat’ or
‘mutationally robust’ fitness landscape can be modeled in two
dimensions as a broad plateau of sequence space populated by a
host of nearly equivalent variants [41,42] that is, a population with
adequate replicative capacity despite substantial degrees of
sequence polymorphism. Our data, derived from in vitro measure-
ments of patient-derived sequences, supports aspects of both of
these models. The restricted variation between average relative
fitness values among chimeras supports the concept of a flat fitness
landscape within env in this patient. The resolution of this
landscape is limited, and more robust sampling and fitness
characterization at each time-point would further elucidate the
topography of the fitness landscape within this or other patients.
However, samples collected from any individual patient, even at
disparate time-points, occupy a very limited portion of the
sequence space being accessed by the global HIV-1 population,
and in each individual, the sequence space explored in Env is
localized around different fitness ‘heights’. It is possible that there
are defined peaks and valleys for fitness within env as a global
population, but again, more robust sampling and fitness charac-
terization would be required to resolve the fitness/replicative
capacity topography of env. It is also possible that different fitness
topographies apply to different HIV-1 gene products due to the
distinct and diverse selective pressures acting on those proteins,
and it is equally conceivable that different topographies might
apply to different domains of Env for the same reason. The current
analyses are admittedly limited by the sequence content available
for analysis, but nevertheless reveal a remarkable fitness landscape
for a functionally critical region of Env.
What fitness topography is being explored by HIV-1 in Env can
only be resolved if more sequences, and more complete env alleles
are subjected to competitive fitness determinations, pitting isolates
against closely related sequences and against those inhabiting
distant regions of sequence space. Here we have developed a
system that makes quantification of fitness by dual infection
competition readily implementable, as well as providing a
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tractable system for quantitatively evaluating various aspects of
HIV biology, or HIV-1-immune response interactions.
Conclusions
To quantitatively evaluate HIV-1 fitness, we generated novel
chimeric HIV-1NL4-3 infectious molecular clones containing
patient 1157i C2-V4 env sequences, which co-expressed either
eGFP or DsRed2 fluorescent reporters upon infection. While the
system was capable of differentiating ‘winners’ and ‘losers’ in
individual competitions with exceptional sensitivity, no chimera
was a universal ‘winner’ or ‘loser’ and fitness phenotypes were not
correlated to a single Env-mediated step in virus entry. Within the
limits of the sample set, the apparent longitudinal pattern of fitness
evolution presented as a flat, near neutral, distribution; one
consistent with the concept of selection of C2-V4 for mutational
robustness.
We conclude that there are multiple pathways to adequate
HIV-1 fitness in Env, but there appears to be no surrogate marker
for HIV-1 fitness; it is optimally quantified by dual-infection
competition.
Methods
Patient 1157i Samples
The Env sequences subjected to analysis here were genetically
characterized previously [60]. Peripheral blood mononuclear cell
(PBMC) DNA samples were collected from a child infected with
HIV-1 (subtype C) in utero in Zambia, Africa, infant 1157 (1157i).
This child underwent limited progression to AIDS without the use
of antiretrovirals, providing the opportunity to investigate the
longitudinal evolution of Env.
Cell Culture
Human embryonic kidney (HEK293T) cells, obtained from
ATCC, and HeLa indicator cells (TZM-bl), obtained from the
NIH AIDS Research and Reference Reagent Program, Division
of AIDS, NIAID, NIH: from Dr. John C. Kappes, Dr. Xiaoyun
Wu and Tranzyme Inc. [92], were maintained in Dulbecco’s
modified Eagle medium (DMEM) supplemented with 10% FBS,
L-glutamine (20 mM), penicillin/streptomycin (100 mg/ml)
(Gibco). Astroglial cells expressing CD4 and CXCR4
(U87.CD4.CXCR4), and CD4 and CCR5 (U87.CD4.CCR5)
were obtained from the AIDS Research and Reference Reagent
Program, Division of AIDS, NIAID, NIH from Dr. Hong Kui
Deng and Dr. Dan R. Littman [93] and maintained in DMEM
supplemented with 15% FBS, L-glutamine (20 mM), penicillin/
streptomycin (100 mg/ml), puromycin (1 mg/ml), G418 (300 mg/
ml) (Gibco).
Primary blood mononuclear cells (PBMC) were isolated from
HIV-seronegative blood donors via Ficoll-Hypaque density
gradient centrifugation (Oklahoma Blood Institute). PBMC were
activated with PHA (5 mg/ml, Sigma) for 48 hours, and then
washed thoroughly in PBS. Untouched CD4+ T-cells were
isolated utilizing Miltenyi CD4+ T-Cell Isolation Kit II (#130-
091-155) and AutoMACS according to manufacturer instructions.
Purified CD4+ T-cells were resuspended in PBMC growth media:
RPMI 1640 supplemented with 10% FBS, L-glutamine (20 mM),
penicillin/streptomycin (100 mg/ml), and IL-2 (10 U/ml, Roche).
Plasmid Construction
Fluorescent protein genes from pNL4-3-Denv-eGFP and pNL4-
3-Denv-DsRed2 (kindly provided by Miguel Quin˜ones-Mateu)
were transferred into pNL4-3-MSS (Multiple Silent Site), using
BamHI (position 8465 in NL4-3) and XhoI (position 8887 in NL4-3)
(New England Biolabs) restriction sites, to generate the infectious
molecular clones pNL4-3-MSS-eGFP and pNL4-3-MSS-DsRed2
(Fig. 1A). The resulting plasmids, NL4-3-MSS-eGFP and NL4-3-
MSS-DsRed2, were sequenced across the junctions 59 and 39 of
the fluorescent reporter gene using primers overlapping the 59
BamHI site (59-TAGTGAACGGATCCTTAGCACTTATC-39)
and 39 XhoI site (59-TTCTAGGTCTCGAGATACTGCTCC-
CAC-39).
Chimeric infectious molecular clones in the Env region were
generated by PCR amplifying archival clones of 1157i C2-V4
sequences in pGEM-T with primers containing the AgeI (59-
CACATGGAATCAGACCGGTAGTATC-39) and SbfI (59-
GTTTTATCCTGCAGGGGAGTGTGATTG-39) restriction sites
to exactly match the sites flanking C2-V4 in the pNL4-3-MSS
vector (position 6970 to 7464 in NL4-3). The resulting PCR
products were digested with the appropriate enzymes (New
England Biolabs) and ligated into a pSP72 subcloning vector,
containing EcoRI-XhoI sequence from NL4-3-MSS. The chimeric
env sequences from the pSP72 vector were then transferred into
NL4-3-MSS-eGFP and NL4-3-MSS-DsRed2 utilizing the EcoRI
(position 5743) and BamHI (position 8465) restriction sites, to
produce a panel of infectious molecular clones identical to one
another, except at the C2-V4 sequence derived from Patient 1157.
NL4-3-MSS-eGFP, NL4-3-MSS-DsRed2 Nef Protein
Expression
In order to make genomic RNA and all of the necessary
mRNAs for protein production from a single LTR promoter,
retroviruses employ an intricate system of splice donors, splice
acceptors, and accessory proteins to regulate expression. Inserting
fluorescent proteins 59 of the nef gene could disrupt Nef
production. To assess Nef protein expression, a control Nef
expression construct pcDNA-Nef was generated by PCR ampli-
fying the NL4-3 nef gene (Forward: 59-CACCATGGGTGG-
CAAGT-39, Reverse: 59-GCAGTTCTTGAAGTACTCCGG-39)
and transferring it into a pcDNA3.1 Directional TOPO vector
(Invitrogen). HEK293T cells in 6-well plates were transfected with
2 mg of the following plasmids using Fugene6 according to
manufacturer’s instructions (Roche): pNL4-3-Denv-eGFP [94],
pcDNA-Nef, NL4-3-MSS, NL4-3-MSS-eGFP or NL4-3-MSS-
DsRed2. 24-hours post transfection, cells were starved for Cys/
Met, followed by radiolabeling with [35S]-Cys/Met (MP biomed-
icals) at 100 mCi/mL for one hour. Cells were lysed (1% NP40,
0.1% SDS, 0.5% DOC in sterile PBS) and immunoprecipitated
with anti-Nef hyperimmune sera (Advanced BioScience Labora-
tories, Inc., #5416). Proteins were resolved on a 12% SDS-PAGE
and quantified by phosphorimager analysis. This procedure was
repeated with mock-transfected cells, NL4-3-MSS, NL4-3-MSS-
eGFP, NL4-3-MSS-DsRed2, and with the original pNL4-3-Denv-
eGFP and pNL4-3-Denv-DsRed2 as described in Weber et al.
Replication Kinetics
Supernatants from NL4-3-MSS-eGFP and NL4-3-MSS-
DsRed2 transfections were 0.45 mm filtered 48-hours post-
transfection and assayed in triplicate for reverse transcriptase
activity according to manufacturer’s instructions (GE, Quan-T-
RT assay system, TRK1022). In a 6-well plate, 105
U87.CD4.CXCR4 were infected with equivalent units of RT
activity of NL4-3-MSS- eGFP, NL4-3-MSS-DsRed2, or Mock.
Three hours post-infection, cells were washed with PBS, and
returned to U87 growth media. Aliquots of 200 ml of infected cell
supernatant from days 2, 4, 6, 8, 10, and 12 post-infection were
filtered and stored at -80 C until the completion of the time course,
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at which time 50 ml of each was used to quantify RT activity in
triplicate.
NL4-3-MSS-eGFP and NL4-3-MSS-DsRed2 Mono and Dual
Infections
NL4-3-MSS-eGFP and NL4-3-MSS-DsRed2 transfection su-
pernatants were filtered 48-hours post-transfection, and titers of
viral stocks were calculated via limiting dilution on TZM-bl
indicator cells. In a 96-well plate, 20,000 TZM-bl cells were
infected with serial dilutions of viral stocks, in triplicate. Forty-
eight hours post-infection, cells were stained in situ for beta-
galactosidase activity. Infectious units (TCID50/ml) were calculat-
ed according to the Reed and Muench method based on staining
endpoints.
Using a MOI of 1.0, 0.1, or 0.01, 20,000 U87.CD4.CXCR4
were infected in triplicate with NL4-3-MSS-eGFP and NL4-3-
MSS-DsRed2 in mono- and dual-infections. Five days post-
infection, U87 cells were trypsinized, resuspended in PBS, and
fixed with paraformaldehyde (final concentration of 0.25%).
Fluorescent cells were quantified from counting 10,000 events
on an Influx cell sorter, excitation 488-nm (eGFP) and 561-nm
(DsRed2). Data was analyzed using Summit v4.3 software.
Quantification of Chimera Fitness
All Env chimeras utilized CCR5 exclusively as a coreceptor (not
shown) as anticipated by the sequences of the V3 terminal
tetrapeptide. Env chimera virus stocks were prepared and titered
as above. For dual-infection competitions in PBMC, CD4+ T-cells
from three donors were aliquoted into 20 wells of a 24-well plate
for individual mock, mono-, and dual infections for the five time-
points. Cells were infected at an MOI of 10. On days 3-7,
fluorescent cells were quantified by counting 50,000 events on an
Influx cell sorter, in triplicate, using the 488-nm (eGFP) and 561-
nm (DsRed2) laser lines. Data was analyzed using Cytopeia
software.
Relative fitness values (W) were calculated as follows [45,48,85]:
WRED = 26(DualRED/MonoRED)/(DualRED/MonoRED)+(-
DualGFP/MonoGFP).
WGFP = 26(DualGFP/MonoGFP)/(DualGFP/Mono-
GFP)+(DualRED/MonoRED).
For dual-infection competitions in U87.CD4.CCR5 cells, all
chimeras (12 in total) were competed against all others (DsRed2
versus eGFP) in triplicate, generating 36 data points for each
chimera (including self-self competitions, used for normalization).
Briefly, in a 96-well plate, 26104 U87.CD4.CCR5 cells were
infected in triplicate at a MOI of 0.1 for eGFP and DsRed2 mono-
infections, eGFP/DsRed2 dual infections were conducted at 0.1
MOI of each chimera, and mock infections served as controls. Five
days post-infection, the infected and dually infected cultures were
analyzed by flow cytometry as above.
Processing, Incorporation, and Infectivity of Chimeric
Envelopes
HEK293T cells were transfected with infant 1157 pNL4-3
eGFP chimeras in quadruplet as described above. Twenty-four
hours post-transfection, cells were starved for Cys/Met and pulse-
labeled with [35S]-Cys/Met (MP Biomedicals) at 100 mCi/mL for
one hour. Cells were lysed (1% NP40, 0.1% SDS, 0.5% DOC in
sterile filtered PBS) at time-point 0 for the ‘pulse’, and complete
media was added to replicate well for 4 hours, 8 hours, and 24
hours ‘chase’ time-points. HIV-1 proteins were immunoprecipi-
tated with HIV-Ig (AIDS Research and Reference Reagent
Program, Division of AIDS, NIAID, NIH: Catalog #3957, HIV-
IG from NABI and NHLBI) and pelleted with Staphylococcus aureus
membranes. Lysates were resolved on 9% SDS-PAGE and the
labeled proteins were quantified by phosphorimagery (Optiquant
software).
Labeled supernatants from the 24-hour time-point were filtered
and 1 ml aliquots were pelleted in a Beckman TLA-55 at
136,0006g at 4uC for one hour. Viral pellets were lysed as above,
and immunoprecipitated with HIV-Ig and S. aureus membranes.
Viral proteins were resolved by 9% SDS-PAGE. Phosphorimager
analysis was used to quantify ratios of gp120 to p66 (RT) as an
index of Env incorporation. The remainder of the radiolabeled
viral stocks was used to infect 26104 TZM-bl cells, in triplicate.
Infectivity was assayed 24-hours post-infection using HIV-induced
luciferase expression (Promega, Victor3). Relative light units
produced in each infection was normalized to the amount of
p66 (from the IP of the viral pellet) in the preparation (RLU/p66)
and this quantity was, in turn, normalized to the incorporation
index (Env/p66). Thus this led to quantification of the RLU/Env,
or the infectivity/Env.
Receptor Affinity via Competition with Anti-CD4 or Anti-
CCR5 Antibodies
To achieve simultaneous addition of virus and antibody to
target cells, 1157 Env chimeric NL4-3 eGFP viral stocks at a MOI
of 0.1 were incubated with serial dilutions of anti-CD4 antibody,
B4 (NIH AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH: Cell Surface CD4 Complex
Monoclonal B4 from United Biomedical Inc. [95]), and the
mixture was added to 20,000 TZM-bl cells in triplicate. TZM-bl
lysates were analyzed 24 hours post-infection for luciferase
expression (Promega) and the IC50 concentration of B4 antibody
was calculated relative to infections without added B4 antibody.
To assess the affinity of the Env CCR5 interaction, the analysis
was repeated with anti-CCR5 antibody, 2D7 (NIH AIDS
Research and Reference Reagent Program, Division of AIDS,
NIAID, NIH: MAb to CCR5 (2D7)). YU2 (a CCR5 tropic virus)
and wild-type NL4-3 (a CXCR4 tropic virus) were included as
controls in both experiments (Fig. S5).
Statistical Analyses
Analyses were carried out using Prism 5.0c for Mac software.
For replication kinetics experiments, the time required to achieve
50% maximal RT activity (RT50) and the ‘HillSlope’ of the
increase in RT activity was calculated by the ‘log(agonist) vs.
response – Variable slope (four parameters)’ subroutine in Prism
(Y = Bottom+(Top-Bottom)/(1+10ˆ((LogEC50-X)*HillSlope)). For
statistical analysis of wild type dual-infection competitions, the
number of fluorescent events in wild-type mono- and dual
infections were compared by 1-way ANOVA at a MOI of 0.1
and 0.01. A one sample t-test was used to compare average fitness
values of chimeras to a theoretical value of 1.0 (neutrality), with a
99% Confidence Interval, to test for deviations from neutrality. To
determine whether average fitness values were different from one
another, the value for each chimera was compared to all others via
a Bonferroni’s Multiple Comparison Test. The IC50 of B4 and
2D7 antibodies was calculated utilizing logarithmic regression
equations contained within Microsoft Excel 2004 for Mac.
Correlations were determined by plotting the relative fitness
values versus the parameter of interest, and by calculating the
Pearson’s correlation coefficient (R2) of the trendline along with
95% confidence intervals (CI).
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Supporting Information
Figure S1 Nef is not expressed from NL4-3-MSS-eGFP or
DsRed2, or ancestral constructs. 293T cells were transfected with
mock (M), pNL4-3-Denv-eGFP [94] (DE), pcDNA-Nef-V5-6xHis
(V5-Nef), NL4-3-MSS (C), NL4-3-MSS-eGFP (G) or NL4-3-MSS-
DsRed2 (R) (left panel) and NL4-3-MSS, NL4-3-MSS-eGFP,
NL4-3-MSS-DsRed2, and with the original pNL4-3-Denv-eGFP
(DEG), and pNL4-3-Denv-DsRed2 (DER) [50]. 35S radiolabeled
transfections were lysed, immunoprecipitated with Nef hyperim-
mune sera, and resolved by SDS-PAGE. If Nef is required,
expression can be regained by inserting a T2A ribosomal skip
sequence at the end of the fluorescent reporter, as described in
Edmonds et al. [96].
(TIF)
Figure S2 Increase in nucleotide and amino acid differences
over time. Average intra time-point differences in nucleotide (blue)
and amino acid (red) sequence over time (N = 23-38 sequences)
based on data from Ref. 60. Over the 67-month sampling period,
average nucleotide diversity within time-points increased at a rate
of 0.2560.045 differences per month; with average amino acid
diversity within time-points increased at a rate of 0.1860.034 per
month. Both were statistically significant positive slopes
(p = 0.0028 and 0.0030 relatively).
(TIF)
Figure S3 Phylogenetic and amino acid analysis of infant 1157
env C2-V4 sequences. Patient env C2-V4 DNA sequences were
aligned with Sequencher 4.8. The resulting alignment was used to
generate an unrooted tree with PhylML [97]. Amino acid
sequences were generated from DNA Strider 1.4. Only positions
where amino acids differ between two or more sequences are
shown. Variable-3 region is highlighted in yellow.
(TIF)
Figure S4 Results from individual patient chimera competitions.
U87.CD4.CCR5 cells were infected at a MOI of 0.1 for all mono-
and dual-infections. Five days post-infection, fluorescent events
were enumerated by flow cytometry and used to calculate relative
fitness values for each competition (see Fig. 3). W values for all
chimeras from all competitions were plotted individually. Circles
represent individual W values, black bars represent means, and
error bars represent standard deviation.
(TIF)
Figure S5 NL4-3 and YU2 controls for CD4 and CCR5 affinity
assay. NL4-3 (CD4, CXCR4) and YU2 (CD4, CCR5) viral stocks
were used as assay controls for the CD4 and CCR5 affinity assays
(Fig. 7). Viral stocks were incubated with serial dilutions of a CD4
competitor (B4 Ab) or CCR5 competitor (2D7 Ab), and added to
TZB-bl indicator cells. Luciferase activity was quantified and used
to calculate IC50 concentrations. While both viruses were
susceptible to competition with the anti-CD4 Ab B4 (NL4-3
IC50 = 4.928 mg/ml), YU2 IC50 = 1.075 mg/ml), only YU2 was
susceptible to competition with the anti-CCR5 Ab 2D7
(IC50 = 0.0280 mg/ml). NL4-3 luciferase activity in the absence
of 2D7 (133,516 RLU630,279) was similar to luciferase activity at
the highest concentrations of 2D7 (0.5 mg/ml) 125,668 RLU
67,940).
(TIF)
Figure S6 Real-Time reagents directed towards eGFP or
DsRed2 are suitable for multiplex reactions. DsRed2 primer-
probe set (DsRed2 Forward: 59-CCTCCTCCGAGAACGT-
CATC-39, Reverse: 59-CCCTCCATGCGCACCTT-39, Probe:
59-CCGAGTTCATGCGCTT-39) was used to detect either 1000
copies of NL4-3-MSS-DsRed2 plasmid (Idealized), 1000 copies of
NL4-3-MSS-DsRed2 in the presence of 1000 copies of NL4-3-
MSS-eGFP (Template interference), 1000 copies of NL4-3-MSS-
DsRed2 in the presence of 1000 copies of NL4-3-MSS-eGFP and
the associated eGFP primer-probe set (eGFP Forward: 59-
GGGCACAAGCTGGAGTACAAC-39, Reverse: 59-
TCTGCTTGTCGGCCATGATA-39, Probe: 59-ACAGCCA-
CAACGTCT-39) (Multiplex), or 10,000 copies of NL4-3-MSS-
eGFP (Irrelevant template) (left panel). NL4-3-MSS-eGFP plasmid
was detected in a similar manner (right panel). Using Bonferroni’s
Multiple Comparison Test, there was no difference between cycle
threshold values of Idealized, Template Interference, or Multiplex
reactions, indicating that the presence of the alternate fluorescent
DNA or reagents does not effect detection. There was a statistically
significant difference between those Cts and the irrelevant
template (p,0.001), indicating that there is no non-specific
amplification of the alternate fluorescent DNA. These primer-
probe sets are suitable for multiplex Real-Time PCR.
(TIF)
Table S1 Column statistics of aggregate data. Statistical analysis
of Figure 4 data (top panel) and One sample t test comparing
average relative fitness values to neutrality (1.0) (bottom panel).
(XLSX)
Table S2 Bonferroni’s Multiple Comparison Test. Data from
each chimera (Fig. 4) was compared against all other chimeras to
determine if the were statistically different. Statistically significant
differences are noted with stars (*, p,0.05; **, p,0.01; ***,
p,0.001).
(XLSX)
Acknowledgments
The authors would like to extend their sincerest thanks to Vinay Pathak
and Gillian Air for critical evaluations and discussions of the manuscript
and the data contained herein. We would like to acknowledge the
contributions of Chipepo Kankasa in the Department of Pediatrics and
Child Health, University Teaching Hospital, Lusaka, Zambia, as well as
her clinical and laboratory staff associated with the Zambia Children’s KS-
HHV-8 Study for their contributions to cohort management, follow-up
and longitudinal sampling.
Author Contributions
Conceived and designed the experiments: JTW. Performed the experi-
ments: SAS. Analyzed the data: SAS JTW. Contributed reagents/
materials/analysis tools: CW. Wrote the paper: SAS JTW CW.
References
1. Jetzt AE, Yu H, Klarmann GJ, Ron Y, Preston BD, et al. (2000) High rate of
recombination throughout the human immunodeficiency virus type 1 genome.
J Virol 74: 1234–1240.
2. Mansky LM, Temin HM (1995) Lower in vivo mutation rate of human
immunodeficiency virus type 1 than that predicted from the fidelity of purified
reverse transcriptase. J Virol 69: 5087–5094.
3. Domingo E, Escarmis C, Sevilla N, Moya A, Elena SF, et al. (1996) Basic
concepts in RNA virus evolution. Faseb J 10: 859–864.
4. McMichael AJ, Phillips RE (1997) Escape of human immunodeficiency virus
from immune control. Annu Rev Immunol 15: 271–296.
5. Metzner KJ, Giulieri SG, Knoepfel SA, Rauch P, Burgisser P, et al. (2009)
Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure
in treatment-naive and -adherent patients. Clin Infect Dis 48: 239–247.
6. Back NK, Nijhuis M, Keulen W, Boucher CA, Oude Essink BO, et al. (1996)
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a
processivity defect of the reverse transcriptase enzyme. EMBO J 15: 4040–4049.
Fitness Relationships in HIV-1 Subtype C Env C2-V4
PLOS ONE | www.plosone.org 16 April 2013 | Volume 8 | Issue 4 | e63094
7. Bangsberg DR (2008) Preventing HIV antiretroviral resistance through better
monitoring of treatment adherence. J Infect Dis 197 Suppl 3: S272–278.
8. Croteau G, Doyon L, Thibeault D, McKercher G, Pilote L, et al. (1997)
Impaired fitness of human immunodeficiency virus type 1 variants with high-
level resistance to protease inhibitors. J Virol 71: 1089–1096.
9. Debyser Z, De Vreese K, Knops-Gerrits PP, Baekelandt V, Bhikhabhai R, et al.
(1993) Kinetics of different human immunodeficiency virus type 1 reverse
transcriptases resistant to human immunodeficiency virus type 1-specific reverse
transcriptase inhibitors. Mol Pharmacol 43: 521–526.
10. Lockman S, Shapiro RL, Smeaton LM, Wester C, Thior I, et al. (2007)
Response to antiretroviral therapy after a single, peripartum dose of nevirapine.
N Engl J Med 356: 135–147.
11. Lucas GM (2005) Antiretroviral adherence, drug resistance, viral fitness and
HIV disease progression: a tangled web is woven. J Antimicrob Chemother 55:
413–416.
12. Nijhuis M, Schuurman R, de Jong D, Erickson J, Gustchina E, et al. (1999)
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of
compensatory mutations during suboptimal therapy. AIDS 13: 2349–2359.
13. Richman D, Shih CK, Lowy I, Rose J, Prodanovich P, et al. (1991) Human
immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of
reverse transcriptase arise in tissue culture. Proc Natl Acad Sci U S A 88: 11241–
11245.
14. Saen-oon S, Aruksakunwong O, Wittayanarakul K, Sompornpisut P, Han-
nongbua S (2007) Insight into analysis of interactions of saquinavir with HIV-1
protease in comparison between the wild-type and G48V and G48V/L90M
mutants based on QM and QM/MM calculations. J Mol Graph Model 26: 720–
727.
15. Sharma PL, Crumpacker CS (1997) Attenuated replication of human
immunodeficiency virus type 1 with a didanosine-selected reverse transcriptase
mutation. J Virol 71: 8846–8851.
16. Palella FJ, Jr., Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998)
Declining morbidity and mortality among patients with advanced human
immunodeficiency virus infection. HIV Outpatient Study Investigators.
N Engl J Med 338: 853–860.
17. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB (1994) Virus-specific
CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in
primary human immunodeficiency virus type 1 infection. J Virol 68: 6103–6110.
18. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, et al.
(2000) HLA B*5701 is highly associated with restriction of virus replication in a
subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A
97: 2709–2714.
19. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, et al.
(2007) CD8+ T-cell responses to different HIV proteins have discordant
associations with viral load. Nat Med 13: 46–53.
20. Wang YE, Li B, Carlson JM, Streeck H, Gladden AD, et al. (2009) Protective
HLA class I alleles that restrict acute-phase CD8+ T-cell responses are
associated with viral escape mutations located in highly conserved regions of
human immunodeficiency virus type 1. J Virol 83: 1845–1855.
21. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, et al. (1994) Temporal
association of cellular immune responses with the initial control of viremia in
primary human immunodeficiency virus type 1 syndrome. J Virol 68: 4650–
4655.
22. Altfeld M, Addo MM, Rosenberg ES, Hecht FM, Lee PK, et al. (2003) Influence
of HLA-B57 on clinical presentation and viral control during acute HIV-1
infection. AIDS 17: 2581–2591.
23. Draenert R, Le Gall S, Pfafferott KJ, Leslie AJ, Chetty P, et al. (2004) Immune
selection for altered antigen processing leads to cytotoxic T lymphocyte escape in
chronic HIV-1 infection. J Exp Med 199: 905–915.
24. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, et al. (2004) HIV
evolution: CTL escape mutation and reversion after transmission. Nat Med 10:
282–289.
25. Miura T, Brumme CJ, Brockman MA, Brumme ZL, Pereyra F, et al. (2009) Hla
Associated Viral Mutations Are Common in Human Immunodeficiency Virus
Type 1 Elite Controllers. J Virol.
26. Fryer HR, Frater J, Duda A, Roberts MG, Phillips RE, et al. (2010) Modelling
the evolution and spread of HIV immune escape mutants. PLoS Pathog 6:
e1001196.
27. Domingo E, Holland JJ (1997) RNA virus mutations and fitness for survival.
Annu Rev Microbiol 51: 151–178.
28. Nara PL, Smit L, Dunlop N, Hatch W, Merges M, et al. (1990) Emergence of
viruses resistant to neutralization by V3-specific antibodies in experimental
human immunodeficiency virus type 1 IIIB infection of chimpanzees. J Virol 64:
3779–3791.
29. Goulder PJ, Bunce M, Krausa P, McIntyre K, Crowley S, et al. (1996) Novel,
cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte
epitopes in slow progressors in HIV type 1 infection. AIDS Res Hum
Retroviruses 12: 1691–1698.
30. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, et al. (1996) Influence of
combinations of human major histocompatibility complex genes on the course of
HIV-1 infection. Nat Med 2: 405–411.
31. Geldmacher C, Currier JR, Herrmann E, Haule A, Kuta E, et al. (2007) CD8 T-
cell recognition of multiple epitopes within specific Gag regions is associated with
maintenance of a low steady-state viremia in human immunodeficiency virus
type 1-seropositive patients. J Virol 81: 2440–2448.
32. Chopera DR, Mlotshwa M, Woodman Z, Mlisana K, de Assis Rosa D, et al.
(2011) Virological and immunological factors associated with HIV-1 differential
disease progression in HLA-B 58:01-positive individuals. J Virol 85: 7070–7080.
33. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, et al. (1998)
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral
RNA. Science 279: 2103–2106.
34. Richman DD, Wrin T, Little SJ, Petropoulos CJ (2003) Rapid evolution of the
neutralizing antibody response to HIV type 1 infection. Proc Natl Acad Sci U S A
100: 4144–4149.
35. Gray ES, Moore PL, Choge IA, Decker JM, Bibollet-Ruche F, et al. (2007)
Neutralizing antibody responses in acute human immunodeficiency virus type 1
subtype C infection. J Virol 81: 6187–6196.
36. Li B, Decker JM, Johnson RW, Bibollet-Ruche F, Wei X, et al. (2006) Evidence
for potent autologous neutralizing antibody titers and compact envelopes in
early infection with subtype C human immunodeficiency virus type 1. J Virol 80:
5211–5218.
37. Wei X, Decker JM, Wang S, Hui H, Kappes JC, et al. (2003) Antibody
neutralization and escape by HIV-1. Nature 422: 307–312.
38. Starcich BR, Hahn BH, Shaw GM, McNeely PD, Modrow S, et al. (1986)
Identification and characterization of conserved and variable regions in the
envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 45: 637–648.
39. Albert J, Abrahamsson B, Nagy K, Aurelius E, Gaines H, et al. (1990) Rapid
development of isolate-specific neutralizing antibodies after primary HIV-1
infection and consequent emergence of virus variants which resist neutralization
by autologous sera. AIDS 4: 107–112.
40. Arendrup M, Nielsen C, Hansen JE, Pedersen C, Mathiesen L, et al. (1992)
Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant
escape virus and subsequent development of escape virus neutralizing antibodies.
J Acquir Immune Defic Syndr 5: 303–307.
41. Wilke CO, Wang JL, Ofria C, Lenski RE, Adami C (2001) Evolution of digital
organisms at high mutation rates leads to survival of the flattest. Nature 412:
331–333.
42. Sardanyes J, Elena SF, Sole RV (2008) Simple quasispecies models for the
survival-of-the-flattest effect: The role of space. J Theor Biol 250: 560–568.
43. Marozsan AJ, Moore DM, Lobritz MA, Fraundorf E, Abraha A, et al. (2005)
Differences in the fitness of two diverse wild-type human immunodeficiency
virus type 1 isolates are related to the efficiency of cell binding and entry. J Virol
79: 7121–7134.
44. Rangel HR, Weber J, Chakraborty B, Gutierrez A, Marotta ML, et al. (2003)
Role of the human immunodeficiency virus type 1 envelope gene in viral fitness.
J Virol 77: 9069–9073.
45. Quinones-Mateu ME, Ball SC, Marozsan AJ, Torre VS, Albright JL, et al.
(2000) A dual infection/competition assay shows a correlation between ex vivo
human immunodeficiency virus type 1 fitness and disease progression. J Virol 74:
9222–9233.
46. Ball SC, Abraha A, Collins KR, Marozsan AJ, Baird H, et al. (2003) Comparing
the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates
of subtypes B and C. J Virol 77: 1021–1038.
47. Kong X, West JT, Zhang H, Shea DM, M’Soka TJ, et al. (2008) The human
immunodeficiency virus type 1 envelope confers higher rates of replicative fitness
to perinatally transmitted viruses than to nontransmitted viruses. J Virol 82:
11609–11618.
48. Troyer RM, Collins KR, Abraha A, Fraundorf E, Moore DM, et al. (2005)
Changes in human immunodeficiency virus type 1 fitness and genetic diversity
during disease progression. J Virol 79: 9006–9018.
49. Holland JJ, de la Torre JC, Clarke DK, Duarte E (1991) Quantitation of relative
fitness and great adaptability of clonal populations of RNA viruses. J Virol 65:
2960–2967.
50. Weber J, Weberova J, Carobene M, Mirza M, Martinez-Picado J, et al. (2006)
Use of a novel assay based on intact recombinant viruses expressing green
(EGFP) or red (DsRed2) fluorescent proteins to examine the contribution of pol
and env genes to overall HIV-1 replicative fitness. J Virol Methods 136: 102–
117.
51. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR (1991) Identification of the
envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science
253: 71–74.
52. Clevestig P, Pramanik L, Leitner T, Ehrnst A (2006) CCR5 use by human
immunodeficiency virus type 1 is associated closely with the gp120 V3 loop N-
linked glycosylation site. J Gen Virol 87: 607–612.
53. Bosch ML, Earl PL, Fargnoli K, Picciafuoco S, Giombini F, et al. (1989)
Identification of the fusion peptide of primate immunodeficiency viruses. Science
244: 694–697.
54. Jones PL, Korte T, Blumenthal R (1998) Conformational changes in cell surface
HIV-1 envelope glycoproteins are triggered by cooperation between cell surface
CD4 and co-receptors. J Biol Chem 273: 404–409.
55. Margolis L, Shattock R (2006) Selective transmission of CCR5-utilizing HIV-1:
the ‘gatekeeper’ problem resolved? Nat Rev Microbiol 4: 312–317.
56. Lobritz MA, Marozsan AJ, Troyer RM, Arts EJ (2007) Natural variation in the
V3 crown of human immunodeficiency virus type 1 affects replicative fitness and
entry inhibitor sensitivity. J Virol 81: 8258–8269.
57. McKeating JA, Gow J, Goudsmit J, Pearl LH, Mulder C, et al. (1989)
Characterization of HIV-1 neutralization escape mutants. Aids 3: 777–784.
58. Derdeyn CA, Decker JM, Sfakianos JN, Wu X, O’Brien WA, et al. (2000)
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20
Fitness Relationships in HIV-1 Subtype C Env C2-V4
PLOS ONE | www.plosone.org 17 April 2013 | Volume 8 | Issue 4 | e63094
is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol
74: 8358–8367.
59. Kuhmann SE, Pugach P, Kunstman KJ, Taylor J, Stanfield RL, et al. (2004)
Genetic and phenotypic analyses of human immunodeficiency virus type 1
escape from a small-molecule CCR5 inhibitor. J Virol 78: 2790–2807.
60. Zhang H, Hoffmann F, He J, He X, Kankasa C, et al. (2005) Evolution of
subtype C HIV-1 Env in a slowly progressing Zambian infant. Retrovirology 2:
67.
61. Abraha A, Troyer RM, Quinones-Mateu ME, Arts EJ (2005) Methods to
determine HIV-1 ex vivo fitness. Methods Mol Biol 304: 355–368.
62. Tso FY, Tully DC, Gonzalez S, Quince C, Ho O, et al. (2012) Dynamics of
envelope evolution in clade C SHIV-infected pig-tailed macaques during disease
progression analyzed by ultra-deep pyrosequencing. PLoS One 7: e32827.
63. Tso FY, Hoffmann FG, Tully DC, Lemey P, Rasmussen RA, et al. (2009) A
comparative study of HIV-1 clade C env evolution in a Zambian infant with an
infected rhesus macaque during disease progression. AIDS 23: 1817–1828.
64. Tebit DM, Nankya I, Arts EJ, Gao Y (2007) HIV diversity, recombination and
disease progression: how does fitness ‘‘fit’’ into the puzzle? AIDS Rev 9: 75–87.
65. Anderson RM, May RM (1996) The population biology of the interaction
between HIV-1 and HIV-2: coexistence or competitive exclusion? AIDS 10:
1663–1673.
66. Arien KK, Abraha A, Quinones-Mateu ME, Kestens L, Vanham G, et al. (2005)
The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1)
group M, HIV-1 group O, and HIV-2 isolates. J Virol 79: 8979–8990.
67. Biesinger T, Kimata JT (2008) HIV-1 Transmission, Replication Fitness and
Disease Progression. Virology (Auckl) 2008: 49–63.
68. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, et al. (2008)
Identification and characterization of transmitted and early founder virus
envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105: 7552–
7557.
69. Kimata JT (2006) HIV-1 fitness and disease progression: insights from the SIV-
macaque model. Curr HIV Res 4: 65–77.
70. Gause GF (1934) Experimental Analysis of Vito Volterra’s Mathematical
Theory of the Struggle for Existence. Science 79: 16–17.
71. Clarke DK, Duarte EA, Elena SF, Moya A, Domingo E, et al. (1994) The red
queen reigns in the kingdom of RNA viruses. Proc Natl Acad Sci U S A 91:
4821–4824.
72. Sole RV, Ferrer R, Gonzalez-Garcia I, Quer J, Domingo E (1999) Red queen
dynamics, competition and critical points in a model of RNA virus quasispecies.
J Theor Biol 198: 47–59.
73. Weber J, Rangel HR, Chakraborty B, Tadele M, Martinez MA, et al. (2003) A
novel TaqMan real-time PCR assay to estimate ex vivo human immunodefi-
ciency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral
therapy. J Gen Virol 84: 2217–2228.
74. Anastassopoulou CG, Marozsan AJ, Matet A, Snyder AD, Arts EJ, et al. (2007)
Escape of HIV-1 from a small molecule CCR5 inhibitor is not associated with a
fitness loss. PLoS Pathog 3: e79.
75. Song H, Pavlicek JW, Cai F, Bhattacharya T, Li H, et al. (2012) Impact of
immune escape mutations on HIV-1 fitness in the context of the cognate
transmitted/founder genome. Retrovirology 9: 89.
76. Schlub TE, Smyth RP, Grimm AJ, Mak J, Davenport MP (2010) Accurately
measuring recombination between closely related HIV-1 genomes. PLoS
Comput Biol 6: e1000766.
77. Batorsky R, Kearney MF, Palmer SE, Maldarelli F, Rouzine IM, et al. (2011)
Estimate of effective recombination rate and average selection coefficient for
HIV in chronic infection. Proc Natl Acad Sci U S A 108: 5661–5666.
78. Chalfie M, Tu Y, Euskirchen G, Ward WW, Prasher DC (1994) Green
fluorescent protein as a marker for gene expression. Science 263: 802–805.
79. Yanushevich YG, Staroverov DB, Savitsky AP, Fradkov AF, Gurskaya NG, et
al. (2002) A strategy for the generation of non-aggregating mutants of Anthozoa
fluorescent proteins. FEBS Lett 511: 11–14.
80. Zhang H, Hoffmann F, He J, He X, Kankasa C, et al. (2006) Characterization of
HIV-1 subtype C envelope glycoproteins from perinatally infected children with
different courses of disease. Retrovirology 3: 73.
81. Javaherian K, Langlois AJ, LaRosa GJ, Profy AT, Bolognesi DP, et al. (1990)
Broadly neutralizing antibodies elicited by the hypervariable neutralizing
determinant of HIV-1. Science 250: 1590–1593.
82. Corzana F, Busto JH, Jimenez-Oses G, Garcia de Luis M, Asensio JL, et al.
(2007) Serine versus threonine glycosylation: the methyl group causes a drastic
alteration on the carbohydrate orientation and on the surrounding water shell.
J Am Chem Soc 129: 9458–9467.
83. Bunnik EM, Lobbrecht MS, van Nuenen AC, Schuitemaker H (2010) Escape
from autologous humoral immunity of HIV-1 is not associated with a decrease in
replicative capacity. Virology 397: 224–230.
84. van Gils MJ, Bunnik EM, Burger JA, Jacob Y, Schweighardt B, et al. (2010)
Rapid escape from preserved cross-reactive neutralizing humoral immunity
without loss of viral fitness in HIV-1-infected progressors and long-term
nonprogressors. J Virol 84: 3576–3585.
85. Troyer RM, McNevin J, Liu Y, Zhang SC, Krizan RW, et al. (2009) Variable
fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL)
response. PLoS Pathog 5: e1000365.
86. Sather DN, Carbonetti S, Kehayia J, Kraft Z, Mikell I, et al. (2012) Broadly
neutralizing antibodies developed by an HIV-positive elite neutralizer exact a
replication fitness cost on the contemporaneous virus. J Virol 86: 12676–12685.
87. Bar KJ, Tsao CY, Iyer SS, Decker JM, Yang Y, et al. (2012) Early low-titer
neutralizing antibodies impede HIV-1 replication and select for virus escape.
PLoS Pathog 8: e1002721.
88. Mikell I, Sather DN, Kalams SA, Altfeld M, Alter G, et al. (2011) Characteristics
of the earliest cross-neutralizing antibody response to HIV-1. PLoS Pathog 7:
e1001251.
89. Lassen KG, Lobritz MA, Bailey JR, Johnston S, Nguyen S, et al. (2009) Elite
suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry
efficiency and kinetics. PLoS Pathog 5: e1000377.
90. Sterjovski J, Churchill MJ, Roche M, Ellett A, Farrugia W, et al. (2011) CD4-
binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4
interactions and fusogenicity. Virology 410: 418–428.
91. Thenin S, Samleerat T, Tavernier E, Ngo-Giang-Huong N, Jourdain G, et al.
(2012) Envelope glycoproteins of human immunodeficiency virus type 1 variants
issued from mother-infant pairs display a wide spectrum of biological properties.
Virology 426: 12–21.
92. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D (1998) Effects of
CCR5 and CD4 cell surface concentrations on infections by macrophagetropic
isolates of human immunodeficiency virus type 1. J Virol 72: 2855–2864.
93. Bjorndal A, Deng H, Jansson M, Fiore JR, Colognesi C, et al. (1997) Coreceptor
usage of primary human immunodeficiency virus type 1 isolates varies according
to biological phenotype. J Virol 71: 7478–7487.
94. Pierson TC, Zhou Y, Kieffer TL, Ruff CT, Buck C, et al. (2002) Molecular
characterization of preintegration latency in human immunodeficiency virus
type 1 infection. J Virol 76: 8518–8531.
95. Wang CY, Sawyer LS, Murthy KK, Fang X, Walfield AM, et al. (1999)
Postexposure immunoprophylaxis of primary isolates by an antibody to HIV
receptor complex. Proc Natl Acad Sci U S A 96: 10367–10372.
96. Edmonds TG, Ding H, Yuan X, Wei Q, Smith KS, et al. (2010) Replication
competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the
analysis of antibody inhibition in PBMC. Virology 408: 1–13.
97. Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate
large phylogenies by maximum likelihood. Syst Biol 52: 696–704.
Fitness Relationships in HIV-1 Subtype C Env C2-V4
PLOS ONE | www.plosone.org 18 April 2013 | Volume 8 | Issue 4 | e63094
